Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASA in depression
IRCT20181007041268N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin in major depressive disorder (MDD), sponsored by Zahedan University of Medical Sciences. Started Dec 2018; status: completed.
02
Drugs
aspirin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20181007041268N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181007041268N1.